Elevated Prolactin Symptoms: When to See a Doctor

What Is Hyperprolactinemia and Why Does It Happen?

Hyperprolactinemia is a persistently high level of prolactin, the pituitary hormone that drives breast milk production. Outside of pregnancy and breastfeeding, prolactin should remain low. When it climbs without a physiological reason, it suppresses gonadotropin-releasing hormone (GnRH), which in turn blunts LH and FSH, disrupting the entire reproductive axis [1].

The Normal Prolactin Range

The Endocrine Society's 2011 Clinical Practice Guideline defines the upper limit of normal as roughly 25 ng/mL in women and 17 ng/mL in men when measured in a fasting, non-stressed state [1]. Levels can transiently spike after meals, exercise, nipple stimulation, or even venipuncture stress, so a single mildly elevated result (25 to 40 ng/mL) often warrants a repeat test before any diagnosis is made [2].

Prolactinomas: The Most Common Pathological Cause

A prolactinoma is a benign pituitary adenoma that secretes prolactin autonomously. Microprolactinomas (<10 mm) account for about 40% of all pituitary adenomas and are far more common in women [3]. Macroprolactinomas (>10 mm) are rarer but more likely to cause mass-effect symptoms such as headache and visual field defects due to compression of the optic chiasm [3].

Population-based studies estimate the prevalence of prolactinomas at 50 per 100,000 people, making them the most frequent hormone-secreting pituitary tumor [4].

Medication-Induced Hyperprolactinemia

Drugs that block dopamine, the neurotransmitter that normally suppresses prolactin, are the second most common cause. The main offenders include:

• Antipsychotics: haloperidol, risperidone, chlorpromazine
• Antidepressants: certain SSRIs and tricyclics (less pronounced effect)
• Antiemetics: metoclopramide, domperidone
• Antihypertensives: methyldopa, verapamil
• Opioids: chronic use consistently raises prolactin via mu-receptor pathways [5]

A 2013 systematic review in the British Journal of Clinical Pharmacology found that risperidone produced the highest prolactin elevations among antipsychotics, with mean levels reaching 45 to 80 ng/mL in women [5].

Other Causes

Primary hypothyroidism raises thyrotropin-releasing hormone (TRH), which directly stimulates prolactin secretion. Chronic kidney disease reduces prolactin clearance. Chest wall injuries, herpes zoster affecting thoracic dermatomes, and even repeated nipple self-examination can trigger reflex prolactin release via afferent neural pathways [6].

Symptoms of Elevated Prolactin in Women

In women, high prolactin suppresses estrogen and progesterone, producing a recognizable cluster of reproductive and systemic effects [1].

Menstrual and Fertility Changes

• Oligomenorrhea (cycles longer than 35 days) or amenorrhea (no period for 3+ months) affects 80 to 90% of women with symptomatic hyperprolactinemia [7].
• Anovulatory cycles cause infertility even when periods appear to continue.
• Shortened luteal phase and low progesterone can mimic other hormonal disorders.

The American Society for Reproductive Medicine (ASRM) recommends measuring serum prolactin in all women presenting with unexplained infertility or ovulatory dysfunction [8].

Galactorrhea

Spontaneous or expressed milky nipple discharge outside of pregnancy or more than 12 months after stopping breastfeeding is called galactorrhea. It occurs in 30 to 80% of women with hyperprolactinemia [7]. Bilateral, multi-duct discharge is more characteristic of hormonal causes; unilateral, single-duct discharge warrants evaluation for intraductal pathology independent of prolactin levels.

Sexual and Genitourinary Symptoms

Estrogen suppression leads to vaginal dryness, dyspareunia, and reduced libido. These symptoms are often mistaken for perimenopause, particularly in women in their late 30s and 40s [2]. Bone density loss also begins within 12 to 18 months of sustained estrogen deficiency, so untreated hyperprolactinemia carries a real long-term skeletal risk [6].

Symptoms of Elevated Prolactin in Men

Men with hyperprolactinemia are frequently diagnosed late because the symptoms are less specific and often attributed to other causes [4].

Sexual and Reproductive Effects

• Reduced libido is the most common presenting complaint, reported by more than 80% of affected men [4].
• Erectile dysfunction follows from both direct prolactin effects on penile tissue and indirect testosterone suppression.
• Low testosterone secondary to suppressed LH is found in the majority of men with prolactinomas [3].
• Oligospermia or azoospermia can result, though sperm production often recovers after prolactin normalization [8].

Gynecomastia and Galactorrhea

Approximately 15 to 20% of men with hyperprolactinemia develop gynecomastia. Galactorrhea in men is less common (fewer than 10% of cases) but highly specific for significant prolactin elevation when it does appear [4].

Mass-Effect Symptoms in Men With Macroprolactinomas

Because men often present later, their prolactinomas tend to be larger at diagnosis. Headache (typically bitemporal and dull), bitemporal hemianopia from optic chiasm compression, and cranial nerve palsies can all occur with macroprolactinomas [3]. Any man with new-onset sexual dysfunction combined with headache or visual changes needs pituitary imaging, not just a testosterone check.

When to See a Doctor: Specific Thresholds

Most people wonder whether their symptoms are serious enough to warrant medical attention. The short answer: yes, if any of the following apply.

See Your Doctor Within 1 to 2 Weeks If You Have:

• Periods that have become irregular or stopped without an obvious cause (pregnancy ruled out)
• Milky nipple discharge unrelated to breastfeeding
• Unexplained low libido or erectile dysfunction lasting more than 4 to 6 weeks
• Infertility after 6 to 12 months of trying to conceive
• A prolactin level above 25 ng/mL on a lab report, even without symptoms

See Your Doctor the Same Day If You Have:

• A prolactin level above 200 ng/mL (strongly suggests macroprolactinoma) [1]
• New or worsening headache combined with any visual disturbance
• Visual field loss, double vision, or drooping eyelid

Go to the Emergency Room Immediately If You Have:

• Sudden severe "thunderclap" headache with or without visual loss, this may indicate pituitary apoplexy, a hemorrhagic emergency requiring urgent neurosurgical evaluation [3].

The Endocrine Society's guideline states directly: "We recommend measuring serum prolactin in all patients with signs or symptoms suggestive of hyperprolactinemia... And performing a pituitary MRI in patients with confirmed hyperprolactinemia after physiological and pharmacological causes are excluded" [1].

How Elevated Prolactin Is Diagnosed

Diagnosis requires confirming a true, persistent elevation and then finding its cause [2].

Step 1: Serum Prolactin Measurement

Draw blood in a fasting, resting state, ideally between 8 and 10 AM, at least 2 hours after waking [1]. If the result is mildly elevated (25 to 100 ng/mL), repeat it on a separate day. Macroprolactin (a large, biologically inactive prolactin-IgG complex) can cause falsely elevated readings; most labs can perform a polyethylene glycol (PEG) precipitation test to rule this out [2].

Step 2: Exclude Physiological and Drug Causes

Before ordering imaging, rule out pregnancy (beta-hCG), hypothyroidism (TSH), chronic kidney disease (creatinine), and any prolactin-raising medications [6]. Stopping the offending drug for 3 days (where clinically safe) often normalizes prolactin, confirming the cause [5].

Step 3: Pituitary MRI

Gadolinium-enhanced MRI of the pituitary gland is the imaging standard. It distinguishes microprolactinomas from macroprolactinomas and identifies other sellar masses (craniopharyngioma, meningioma, Rathke cleft cyst) that compress the pituitary stalk and raise prolactin indirectly, a phenomenon called the "stalk effect" [3].

Step 4: Visual Field Testing

Formal perimetry (Humphrey visual field testing) is indicated for all macroprolactinomas and for any patient with a visual complaint, because chiasmal compression can progress silently [1].

Causes of Elevated Prolactin: A Diagnostic Summary

| Category | Examples | Typical Prolactin Level | |---|---|---| | Physiological | Pregnancy, breastfeeding, stress, sleep | 25 to 300 ng/mL | | Prolactinoma | Micro or macro adenoma | 100 to 10,000+ ng/mL | | Medications | Risperidone, metoclopramide, opioids | 25 to 200 ng/mL | | Hypothyroidism | Primary, untreated | 25 to 100 ng/mL | | Renal failure | GFR <30 mL/min/1.73 m² | 25 to 100 ng/mL | | Stalk effect | Non-secreting pituitary mass | Usually <150 ng/mL | | Chest wall / neurogenic | Rib fracture, zoster, surgery | 25 to 60 ng/mL |

A prolactin level above 250 ng/mL almost always indicates a prolactinoma rather than a medication or stalk-effect cause [1].

Treatment Options for Elevated Prolactin

Dopamine Agonists: First-Line Therapy

Cabergoline (Dostinex) and bromocriptine (Parlodel) mimic dopamine and directly suppress prolactin secretion. The Endocrine Society recommends cabergoline over bromocriptine because of superior efficacy and tolerability [1].

In a landmark randomized trial published in the New England Journal of Medicine, cabergoline normalized prolactin in 83% of patients with microprolactinomas versus 59% with bromocriptine, and restored ovulatory cycles in 72% versus 52% (P<0.001) [9]. Typical dosing starts at 0.25 mg twice weekly and titrates to 0.5 to 1 mg twice weekly based on prolactin response [1].

Side effects, nausea, dizziness, and orthostatic hypotension, affect about 5 to 10% of patients at standard doses and are generally mild [9]. At doses above 3 mg/day (used in Parkinson's disease, not prolactinoma), cardiac valve changes have been reported, but prolactinoma doses remain well below this threshold [10].

Tumor Size Reduction

Dopamine agonists also shrink the tumor. A 2006 meta-analysis in the Journal of Clinical Endocrinology and Metabolism found that cabergoline reduced macroprolactinoma volume by more than 25% in 67% of patients and by more than 50% in 42% after 12 months of treatment [4]. MRI is typically repeated at 6 to 12 months to assess response.

Surgery

Transsphenoidal surgery is reserved for patients who cannot tolerate dopamine agonists, have drug-resistant tumors, or present with acute visual loss from chiasmal compression [3]. Surgical remission rates for microprolactinomas reach 80 to 90% in experienced centers, but the recurrence rate at 10 years is roughly 20% [3].

Radiation

Stereotactic radiosurgery (e.g., Gamma Knife) is a third-line option for aggressive or recurrent tumors not controlled by medication or surgery. It normalizes prolactin in 25 to 50% of cases but carries a 30 to 50% risk of hypopituitarism over 10 years [3].

Treating Medication-Induced Hyperprolactinemia

If an antipsychotic is the cause, switching to a prolactin-sparing agent (quetiapine, aripiprazole, or clozapine) often resolves the problem without sacrificing psychiatric control [5]. This decision requires coordination between the prescribing psychiatrist and an endocrinologist.

Addressing Bone Loss

Women with hyperprolactinemia-induced amenorrhea lasting more than 6 months should have a DXA scan, because trabecular bone loss is measurable by that point [6]. Restoring normal prolactin (and thus estrogen) is usually sufficient to halt further bone loss; add-back estrogen therapy is an option when conception is not desired [1].

Living With Hyperprolactinemia: What to Expect Long-Term

Most patients on cabergoline see prolactin normalize within 3 to 6 months. Periods typically resume within 3 months of normalization [7]. Fertility usually returns, and pregnancy on cabergoline is generally considered safe, though the standard practice is to stop the drug once pregnancy is confirmed for microprolactinoma patients [1].

After 2 years of normal prolactin levels and stable or absent tumor on MRI, the Endocrine Society recommends a gradual cabergoline taper. Remission (defined as normal prolactin off medication) occurs in up to 70% of microprolactinoma patients who are treated for at least 2 years [1].

Macroprolactinoma patients require longer treatment and more frequent monitoring, including annual MRI for the first 3 years and repeat visual field testing whenever headache or visual symptoms change [3].